The ethics surrounding CRISPR, a revolutionary gene editing technology, spark intense debate in scientific and societal circles alike.As researchers make strides in potential applications like a cure for sickle cell, they face looming questions about the ethical implications of CRISPR and its broader impact on health justice.
Gene editing has emerged as a groundbreaking innovation in the field of genetics, offering the potential to rewrite humanity’s genetic destiny.With techniques like CRISPR, base editing, and prime editing leading the way, researchers are now able to tackle genetic disorders that once seemed insurmountable.
Prion disease treatment is on the brink of a breakthrough, thanks to groundbreaking research driven by a passionate team of scientists and patient advocates.This collection of rare, fatal conditions, including Creutzfeldt-Jakob disease and fatal familial insomnia, has long eluded effective therapies due to the intricate nature of misfolded proteins in the brain.
The 2025 Breakthrough Prizes, often referred to as the “Oscars of Science,” recently honored three remarkable Harvard scientists for their groundbreaking contributions in the fields of gene editing, multiple sclerosis research, and obesity treatment.Alberto Ascherio’s pivotal work linked the Epstein-Barr virus to multiple sclerosis, providing a crucial understanding of this debilitating disease that affects millions globally.